fda_483 · inspection_citation · high

SCA Pharmaceuticals Inc -- FDA 483: 3 observations (2025-10-30)

Event date
2025-10-30 00:00:00Z
Observed
2026-07-12 22:31:32Z
Source ID
3010683157-2025-10-30-190196
Payload hash
c1451ab41c0595ad9c17460d

Summary

Observation 1: Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established. Specifically, Your firm failed to establish adequate procedur...

Informational only. Not legal, financial, or medical advice.